BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30420089)

  • 1. End-organ effects of primary hyperparathyroidism: A population-based study.
    Assadipour Y; Zhou H; Kuo EJ; Haigh PI; Adams AL; Yeh MW
    Surgery; 2019 Jan; 165(1):99-104. PubMed ID: 30420089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patients with primary hyperparathyroidism--why do some form stones?
    Berger AD; Wu W; Eisner BH; Cooperberg MR; Duh QY; Stoller ML
    J Urol; 2009 May; 181(5):2141-5. PubMed ID: 19296981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stones left unturned: Missed opportunities to diagnose primary hyperparathyroidism in patients with nephrolithiasis.
    Lui MS; Fisher JC; Underwood HJ; Patel KN; Ogilvie JB
    Surgery; 2022 Jan; 171(1):23-28. PubMed ID: 34330541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypomagnesuria is Associated With Nephrolithiasis in Patients With Asymptomatic Primary Hyperparathyroidism.
    Saponaro F; Marcocci C; Apicella M; Mazoni L; Borsari S; Pardi E; Di Giulio M; Carlucci F; Scalese M; Bilezikian JP; Cetani F
    J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32369583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of obesity on the presentation of primary hyperparathyroidism.
    Tran H; Grange JS; Adams-Huet B; Nwariaku FE; Rabaglia JL; Woodruff SL; Holt SA; Maalouf NM
    J Clin Endocrinol Metab; 2014 Jul; 99(7):2359-64. PubMed ID: 24684459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current opinions on nephrolithiasis associated with primary hyperparathyroidism.
    Cong X; Shen L; Gu X
    Urolithiasis; 2018 Oct; 46(5):453-457. PubMed ID: 29350243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary hyperparathyroidism.
    Oberger Marques JV; Moreira CA
    Best Pract Res Clin Rheumatol; 2020 Jun; 34(3):101514. PubMed ID: 32336576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sporadic primary hyperparathyroidism and stone disease: a comprehensive metabolic evaluation before and after parathyroidectomy.
    Marchini GS; Faria KVM; Torricelli FCM; Monga M; Srougi M; Nahas WC; Mazzucchi E
    BJU Int; 2018 Feb; 121(2):281-288. PubMed ID: 29124877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recognition of primary hyperparathyroidism: Delayed time course from hypercalcemia to surgery.
    Naples R; Shin JJ; Berber E; Jin J; Krishnamurthy VD; Siperstein AE
    Surgery; 2020 Feb; 167(2):358-364. PubMed ID: 31561989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypercalciuria: its value as a predictive risk factor for nephrolithiasis in asymptomatic primary hyperparathyroidism?
    Saponaro F; Cetani F; Mazoni L; Apicella M; Di Giulio M; Carlucci F; Scalese M; Pardi E; Borsari S; Bilezikian JP; Marcocci C
    J Endocrinol Invest; 2020 May; 43(5):677-682. PubMed ID: 31873910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normocalcaemic primary hyperparathyroidism: is nephrolithiasis more common than osteoporosis?
    Wu KCJ; Anpalahan M
    Intern Med J; 2023 Jan; 53(1):112-118. PubMed ID: 34435736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normohormonal primary hyperparathyroidism is a distinct form of primary hyperparathyroidism.
    Applewhite MK; White MG; Tseng J; Mohammed MK; Mercier F; Kaplan EL; Angelos P; Vokes T; Grogan RH
    Surgery; 2017 Jan; 161(1):62-69. PubMed ID: 27866715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in metabolic urinary abnormalities in stone forming and nonstone forming patients with primary hyperparathyroidism.
    Sorensen MD; Duh QY; Grogan RH; Tran TC; Stoller ML
    Surgery; 2012 Mar; 151(3):477-83. PubMed ID: 21893327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parathyroidectomy for nephrolithiasis in primary hyperparathyroidism: Beneficial but not a panacea.
    Huang SY; Burchette R; Chung J; Haigh PI
    Surgery; 2022 Jan; 171(1):29-34. PubMed ID: 34364687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of Renal Function and Calcifications in Primary Hyperparathyroidism: A Nested Case-Control Study.
    Ejlsmark-Svensson H; Bislev LS; Rolighed L; Sikjaer T; Rejnmark L
    J Clin Endocrinol Metab; 2018 Sep; 103(9):3574-3583. PubMed ID: 29955845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can biochemical abnormalities predict symptomatology in patients with primary hyperparathyroidism?
    Bargren AE; Repplinger D; Chen H; Sippel RS
    J Am Coll Surg; 2011 Sep; 213(3):410-4. PubMed ID: 21723154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary hyperparathyroidism, hypercalciuria, and bone recovery after parathyroidectomy.
    Nilsson IL; Norenstedt S; Zedenius J; Pernow Y; Bränström R
    Surgery; 2017 Aug; 162(2):429-436. PubMed ID: 28522130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary Hyperparathyroidism: Effects on Bone Health.
    Zanocco KA; Yeh MW
    Endocrinol Metab Clin North Am; 2017 Mar; 46(1):87-104. PubMed ID: 28131138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary hyperparathyroidism and nephrolithiasis.
    Vestergaard P
    Ann Endocrinol (Paris); 2015 May; 76(2):116-9. PubMed ID: 25911000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of nephrolithiasis in a renal transplant patient during treatment with Cinacalcet.
    Seager CM; Srinivas TR; Flechner SM
    Ann Transplant; 2013 Jan; 18():31-5. PubMed ID: 23792498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.